Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pulmonary Disease Physician in New York, NY
NPI: 1407933195Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get M.D. Emily's Phone Numberphone_androidMobile
Get M.D. Emily's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1991 - 2026
American Board of Internal Medicine
Pulmonary Disease
New York Presbyterian Hospital (Columbia Campus)
Fellowship • Pulmonary Disease and Critical Care Medicine
1992 - 1994
Residency • Internal Medicine
1989 - 1992
New York University School of Medicine
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 160 | 203 |
| 2 | 94375Test to measure rate of airflow | 110 | 113 |
| 3 | 94729Measurement of lung diffusing capacity | 95 | 97 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 54 | 88 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 42 | 64 |
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.
Authors: Katherine Cahill, Joshua Boyce, Kartik Shenoy, Jennifer Trevor
Publication Date: 2017-05-18
Survival in cystic fibrosis after acute respiratory failure supported by extracorporeal membrane oxygenation and/or invasive mechanical ventilation.
Authors: Jenna Gibilaro, Luke Benvenuto, Claire Keating
Publication Date: 2021-05-25
Lead Sponsor: National Jewish Health
Collaborators: Cystic Fibrosis Foundation, Children's Hospital Colorado
Lead Sponsor: Columbia University
Collaborators: National Institute of Nursing Research (NINR), Clinical Directors Network
Lead Sponsor: University of North Carolina, Chapel Hill
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: OTHER: Placebo, DRUG: Clazakizumab, DRUG: Imatinib Mesylate, DRUG: Cavosonstat, DRUG: MCT, DRUG: Broncho-Vaxom
